Closed Solicitation · DEPT OF DEFENSE

    AMENDMENT 0003 BICALUTAMIDE 50MG & 500MG TABLETS

    Sol. SPE2D2-24-R-0016SolicitationPHILADELPHIA, PA
    Closed
    STATUS
    Closed
    closed Feb 14, 2025
    POSTED
    Feb 4, 2025
    Publication date
    NAICS CODE
    325412
    Primary industry classification
    PSC CODE
    6505
    Product & service classification

    AI Summary

    The Defense Logistics Agency is soliciting bids for a national requirements contract for Bicalutamide 50MG tablets in 30 and 500 count bottles. This unrestricted acquisition includes an estimated annual quantity of 23,529 for 30-count and 1,961 for 500-count bottles. The contract will be firm-fixed price with a one-year base and four options. Proposals can be submitted via DLA Bid Board System and Sam.Gov. For inquiries, contact Keith Ryales at 215-737-9199.

    Contract details

    Solicitation No.
    SPE2D2-24-R-0016
    Notice Type
    Solicitation
    Posted Date
    February 4, 2025
    Response Deadline
    February 14, 2025
    NAICS Code
    325412AI guide
    PSC / Class Code
    6505
    Contract Code
    97AS
    Issuing Office
    DLA TROOP SUPPORT
    Primary Contact
    Keith Ryales
    State
    PA
    ZIP Code
    19111
    AI Product/Service
    product

    Description

    The Defense Logistics Agency is  issue a solicitation for a national requirements contract for Bicalutamide 50MG tablets in bottle counts of 30 and 500. Procurement details follow.

    DESCRIPTION                                                               EST QTY (YR)

    Bicalutamide 50 MG Tablet – 30 Count                               23,529

    Bicalutamide 50 MG Tablet – 500 Count                               1961

    This is an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.  

    A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/

    Interested parties should contact Keith Ryales (215-737-9199) (Keith. Ryales@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is TBA. DLA reserves the right to issue the solicitation before or after the projected solicitation date.

    NOTE:

    \i) Amendment 0001 is Null and Void. Amendment 0001 has been deleted due to systemic issue, this amendment 0002 replaces 0001.
    ii) The Revised Solicitation document is included / embedded in this file. Access the files(s) by following the instruction in order below:


    Using Adobe Acrobat- 1. Go to thumbnail 2. Go to Attachments:(view files attached) (Attachments are under the Paperclip symbol)
    THIS AMENDMENT INCLUDES THE FOLLOWNG: 1) Solicitation Closing Date is herein 02/07/2025 3:00 pm
    2) Page 84 of 97  is has in revised 
    3) All other information in the original solicitation remains the same.

    Key dates

    1. February 4, 2025Posted Date
    2. February 14, 2025Proposals / Responses Due

    AI search tags

    Frequently asked questions

    AMENDMENT 0003 BICALUTAMIDE 50MG & 500MG TABLETS is a federal acquisition solicitation issued by DEPT OF DEFENSE. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.